Am J Epidemiol 2003; 158:77-84.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Exposure to Tricyclic and Selective Serotonin Reuptake Inhibitor Antidepressants and the Risk of Hip Fracture
1 Division of Respiratory Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, England.
2 Division of Statistics, Open University, Milton Keynes, England.
3 Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, London, England.
The use of tricyclic antidepressants is associated with an increased risk of hip fracture. Despite a better side effect profile, this adverse effect has also been reported for selective serotonin reuptake inhibitors. To determine whether these findings result from bias arising from the case-control method, the authors have performed a case-control analysis and a self-controlled case-series analysis using 1987–1999 diagnosis data for 16,341 cases of hip fracture and 29,889 controls drawn from the United Kingdom General Practice Research Database. Both analyses showed an association between hip fracture and antidepressant treatment, and this was most marked during the first 15 days of treatment. The estimates from the case-control study were larger than those from the case-series analysis: The odds ratios for fracture within the first 15 days of a prescription for tricyclic antidepressants and serotonin reuptake inhibitors were 4.76 (95% confidence interval (CI): 3.06, 7.41) and 6.30 (95% CI: 2.65, 14.97), whereas the equivalent incidence ratios were 2.30 (95% CI: 1.82, 2.90) and 1.96 (95% CI: 1.35, 2.83). Tricyclic antidepressants and serotonin reuptake inhibitors are both associated with an independent increase in hip fracture incidence during the first weeks of treatment. The estimates from the case-series analyses were smaller than those from the case-control analyses, suggesting that the case-control method is subject to bias.
antidepressive agents; case-control studies; hip fractures
Abbreviations: Abbreviations: CI, confidence interval; GPRD, General Practice Research Database; IR, incidence ratio; OR, odds ratio; UK, United Kingdom.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Hartikainen, E. Lonnroos, and K. Louhivuori Medication as a Risk Factor for Falls: Critical Systematic Review J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2007; 62(10): 1172 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Diem, T. L. Blackwell, K. L. Stone, K. Yaffe, E. M. Haney, M. M. Bliziotes, and K. E. Ensrud Use of Antidepressants and Rates of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures Arch Intern Med, June 25, 2007; 167(12): 1240 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Haney, B. K. S. Chan, S. J. Diem, K. E. Ensrud, J. A. Cauley, E. Barrett-Connor, E. Orwoll, M. M. Bliziotes, and for the Osteoporotic Fractures in Men Study Group Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men Arch Intern Med, June 25, 2007; 167(12): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Richards, A. Papaioannou, J. D. Adachi, L. Joseph, H. E. Whitson, J. C. Prior, D. Goltzman, and for the Canadian Multicentre Osteoporosis Study (C Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture Arch Intern Med, January 22, 2007; 167(2): 188 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Smeeth, I. Douglas, and R. Hubbard Commentary: We still need observational studies of drugs--they just need to be better. Int. J. Epidemiol., October 1, 2006; 35(5): 1310 - 1311. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Smeeth, P. T Donnan, and D. G Cook The use of primary care databases: case-control and case-only designs Fam. Pract., October 1, 2006; 23(5): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Wilson, G. A. Chase, E. A. Chrischilles, and R. B. Wallace Hip Fracture Risk Among Community-Dwelling Elderly People in the United States: A Prospective Study of Physical, Cognitive, and Socioeconomic Indicators Am J Public Health, July 1, 2006; 96(7): 1210 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Hubbard, S Lewis, J West, C Smith, C Godfrey, L Smeeth, P Farrington, and J Britton Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network Thorax, October 1, 2005; 60(10): 848 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Warden, A. G. Robling, M. S. Sanders, M. M. Bliziotes, and C. H. Turner Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth Endocrinology, February 1, 2005; 146(2): 685 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. JORGE, R. G. ROBINSON, and S. ARDNT Drs. Jorge and Robinson Reply Am J Psychiatry, August 1, 2004; 161(8): 1507 - 1508. [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Farrington RE: "RISK ANALYSIS OF ASEPTIC MENINGITIS AFTER MEASLES-MUMPS-RUBELLA VACCINATION IN KOREAN CHILDREN BY USING A CASE-CROSSOVER DESIGN" Am. J. Epidemiol., April 1, 2004; 159(7): 717 - 718. [Full Text] [PDF]
|
|